Findings

What do systematic reviews say?

4,919 questions · 13,869 findings · 2,177 reviews · Headline outcomes only

Sort:Best matchNewestHighest certainty Download CSV

No studies found 13,869 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Pulsed high‐intensity laser vs Placebo (sham) laser therapy

Adverse events · people with postburn pruritus

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for postburn pruritus 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Doxepin cream vs oral antihistamine

Pain · people with postburn pruritus

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for postburn pruritus 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Gabapentin vs cetirizine (antihistamine)

Pain · people with postburn pruritus

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for postburn pruritus 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Pregabalin vs cetirizine with pheniramine maleate (antihistamine)

Pain · people with postburn pruritus

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for postburn pruritus 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Anti‐CD52 mAb maintenance therapy vs observation

Overall survival ‐ not reported · people with chronic lymphocytic leukaemia

The review found no eligible studies for this question.

1 finding from 1 review

Maintenance therapy for chronic lymphocytic leukaemia 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Anti‐CD52 mAb maintenance therapy vs observation

Health‐related quality of life ‐ not reported · people with chronic lymphocytic leukaemia

The review found no eligible studies for this question.

1 finding from 1 review

Maintenance therapy for chronic lymphocytic leukaemia 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Anti‐CD52 mAb maintenance therapy vs observation

Grades 3 and 4 adverse events ‐ not reported · people with chronic lymphocytic leukaemia

The review found no eligible studies for this question.

1 finding from 1 review

Maintenance therapy for chronic lymphocytic leukaemia 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Anti‐CD52 mAb maintenance therapy vs observation

Treatment‐related mortality ‐ not reported · people with chronic lymphocytic leukaemia

The review found no eligible studies for this question.

1 finding from 1 review

Maintenance therapy for chronic lymphocytic leukaemia 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Anti‐CD52 mAb maintenance therapy vs observation

Treatment discontinuation · people with chronic lymphocytic leukaemia

The review found no eligible studies for this question.

1 finding from 1 review

Maintenance therapy for chronic lymphocytic leukaemia 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Anti‐CD52 mAb maintenance therapy vs observation

All adverse events – not reported · people with chronic lymphocytic leukaemia

The review found no eligible studies for this question.

1 finding from 1 review

Maintenance therapy for chronic lymphocytic leukaemia 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Immunomodulatory drug maintenance therapy vs placebo/observation

Health‐related quality of life ‐ not reported · people with chronic lymphocytic leukaemia

The review found no eligible studies for this question.

1 finding from 1 review

Maintenance therapy for chronic lymphocytic leukaemia 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Pressure‐garment therapy (PGT) plus silicone vs no treatment/lanolin

Scar improvement (POSAS) (0–10, higher score = more severe scarring) · people with burn wounds likely to develop hypertrophic scarring

The review found no eligible studies for this question.

1 finding from 1 review

Pressure‐garment therapy for preventing hypertrophic scarring after burn injury 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Pressure‐garment therapy (PGT) plus silicone vs no treatment/lanolin

Quality of life · people with burn wounds likely to develop hypertrophic scarring

The review found no eligible studies for this question.

1 finding from 1 review

Pressure‐garment therapy for preventing hypertrophic scarring after burn injury 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Pressure‐garment therapy (PGT) vs no treatment/lanolin

Scar improvement (POSAS) (0–10, higher score = more severe scarring) · people with burn wounds likely to develop hypertrophic scarring

The review found no eligible studies for this question.

1 finding from 1 review

Pressure‐garment therapy for preventing hypertrophic scarring after burn injury 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Pressure‐garment therapy (PGT) plus silicone vs no treatment/lanolin

Adherence · people with burn wounds likely to develop hypertrophic scarring

The review found no eligible studies for this question.

1 finding from 1 review

Pressure‐garment therapy for preventing hypertrophic scarring after burn injury 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

High‐pressure garment therapy vs low‐pressure garment therapy

Scar improvement (POSAS) (0–10, higher score = more severe scarring) · people with burn wounds likely to develop hypertrophic scarring

The review found no eligible studies for this question.

1 finding from 1 review

Pressure‐garment therapy for preventing hypertrophic scarring after burn injury 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

High‐pressure garment therapy vs low‐pressure garment therapy

Pain · people with burn wounds likely to develop hypertrophic scarring

The review found no eligible studies for this question.

1 finding from 1 review

Pressure‐garment therapy for preventing hypertrophic scarring after burn injury 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

High‐pressure garment therapy vs low‐pressure garment therapy

Pruritus · people with burn wounds likely to develop hypertrophic scarring

The review found no eligible studies for this question.

1 finding from 1 review

Pressure‐garment therapy for preventing hypertrophic scarring after burn injury 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

High‐pressure garment therapy vs low‐pressure garment therapy

Quality of life · people with burn wounds likely to develop hypertrophic scarring

The review found no eligible studies for this question.

1 finding from 1 review

Pressure‐garment therapy for preventing hypertrophic scarring after burn injury 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Different types of pressure garment (Caroskin Tricot plus an adhesive silicone gel sheet vs Gecko Nanoplast

Scar improvement (POSAS) (0–10, higher score = more severe scarring) · people with burn wounds likely to develop hypertrophic scarring

The review found no eligible studies for this question.

1 finding from 1 review

Pressure‐garment therapy for preventing hypertrophic scarring after burn injury 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found